Another overdose reversal drug reaches the market
Opvee is an inhaled version of nalmefene, a drug approved nearly 30 years ago in injectable and oral forms to reverse opioid overdoses.
Source: politico.com
Shortages Prevention Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Shortages Prevention Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Shortages Prevention Program Today - Breaking & Trending Today
Global Healthcare Industry ESG (Environmental, Social, and Governance) Trends Report 2023: Focus on Healthcare Equipment Providers, Biotech Companies, and Life Sciences Tools and Services Companies
/PRNewswire/ -- The "ESG Trends in the Healthcare Industry" report has been added to ResearchAndMarkets.com's offering. The aim of this study is to evaluate...
Source: prnewswire.com
4 Key Considerations For Onshoring Inbound Medtech Supply Chains
Many medtech supply chains hold a significant amount of redundant inventory, from orthopedic spare parts to unutilized loose instruments. If the...
Source: meddeviceonline.com